Used in research for its potential as a selective inhibitor targeting specific pathways involved in inflammatory and immune-mediated conditions. It has shown promise in preclinical studies for modulating biological responses related to autoimmune diseases. Its high selectivity makes it a candidate for development in targeted therapies, particularly where precise molecular intervention is required. Studies also explore its pharmacokinetic properties to assess viability for oral administration in therapeutic settings.